Overview

Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption

Status:
Terminated
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
Aromatase inhibitors are potent suppressors of breast cancer growth, but side effects include bone loss, fractures, arthralgias and myalgias. We hypothesize vitamin D administration might be beneficial in treating these symptoms and to protect bone.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Mark Pegram
Stanford University
Collaborator:
United States Department of Defense
Treatments:
Ergocalciferols
Vitamin D
Vitamins